Emerging Research and News in Prostate Cancer Imaging — February 2025

News
Slideshow

Catch up on the most-well viewed prostate imaging content in February 2025.

Touching on a variety of topics in prostate cancer imaging, ranging from common contributing factors with false positives and false negatives on prostate MRI to a new meta-analysis on PET/CT radiotracers, here are the top five most well-viewed prostate imaging content from Diagnostic Imaging for February 2025.

Emerging Research and News in Prostate Cancer Imaging — February 2025

Emerging Research and News in Prostate Cancer Imaging — February 2025

Click the arrows above to view top prostate cancer imaging content from February 2025.

Recent Videos
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Can 18F-Flotufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Detecting PCa Recurrence in African Americans: Can 18F-Flotufolastat Have an Impact?
Detecting PCa Recurrence in African Americans: Can 18F-Flotufolastat Have an Impact?
Related Content
Breast MRI-Based Radiomics May Reduce Overtreatment of DCIS

Breast MRI-Based Radiomics May Reduce Overtreatment of DCIS

Jeff Hall
April 1st 2025
Article

New multicenter research suggests that radiomic features derived from breast MRI may enhance prognostic capabilities with disease upstaging for ductal carcinoma in situ (DCIS).

The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET

The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET

Jeff Hall
March 18th 2025
Podcast

In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.

Expanded FDA Approval Allows Use of Pluvicto Prior to Chemotherapy in Patients with mCRPC

Expanded FDA Approval Allows Use of Pluvicto Prior to Chemotherapy in Patients with mCRPC

Jeff Hall
March 28th 2025
Article

Recent research demonstrated a 59 percent reduced risk of progression or death with the radioligand therapy Pluvicto in comparison to a change of androgen receptor pathway inhibitor (ARPI) for patients with metastatic castration-resistant prostate cancer (mCRPC).

MindMoments: Consensus MRI Guidelines for Multiple Sclerosis

MindMoments: Consensus MRI Guidelines for Multiple Sclerosis

Matt Hoffman
July 3rd 2021
Podcast

An interview with two experts to discuss newly released guidance for using standardized MRI protocols for patients with this condition.

Could Microultrasonography-Guided Biopsy be an Alternative to MRI for PCa Detection in Biopsy-Naïve Men?

Could Microultrasonography-Guided Biopsy be an Alternative to MRI for PCa Detection in Biopsy-Naïve Men?

Jeff Hall
March 24th 2025
Article

Microultrasonography-guided biopsy offered comparable detection as MRI/conventional ultrasound-guided biopsy in detection of Gleason grade group 2 or higher prostate cancer, according to a new international multicenter study.

Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?

Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?

Jeff Hall
March 21st 2025
Article

Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.

© 2025 MJH Life Sciences

All rights reserved.